| |
 |
|
Class Information
Number: 514/424
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) > The five-membered hetero ring consists of one nitrogen and four carbons > Chalcogen bonded directly to the five-membered hetero ring by nonionic bonding
Description: Subject matter wherein chalcogen is bonded directly to the five-membered hetero ring by nonionic bonding.
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7608636 |
Medicines for treatment and prevention of neurogenic pain |
Oct. 27, 2009 |
| 7608637 |
Pharmaceutical composition for treatment of diseases associated with decrease in bone mass comprising EP4 agonist as the active ingredient |
Oct. 27, 2009 |
| 7601753 |
Pyrrolidine melanocortin-specific compounds |
Oct. 13, 2009 |
| 7598288 |
Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucoma |
Oct. 6, 2009 |
| 7592364 |
Substituted gamma lactams as therapeutic agents |
Sep. 22, 2009 |
| 7585882 |
Phosphodiesterase 4 inhibitors |
Sep. 8, 2009 |
| 7585887 |
Active agent combinations with insecticidal and acaricidal properties |
Sep. 8, 2009 |
| 7576102 |
Biaryl substituted nitrogen containing heterocycle inhibitors of LTA4H for treating inflammation |
Aug. 18, 2009 |
| 7569598 |
Process for the preparation of the R,R (or S,S) configured glycopyrronium stereoisomer |
Aug. 4, 2009 |
| 7557137 |
Gamma-lactams as beta-secretase inhibitors |
Jul. 7, 2009 |
| 7550502 |
Substituted gamma lactams as therapeutic agents |
Jun. 23, 2009 |
| 7550448 |
Therapeutic compounds |
Jun. 23, 2009 |
| 7550453 |
2-alkoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof |
Jun. 23, 2009 |
| 7547685 |
Therapeutic substituted pyrrolidone compounds |
Jun. 16, 2009 |
| 7544676 |
Sulfamoyl benzamides and methods of their use |
Jun. 9, 2009 |
| 7534790 |
Ion channel modulating compounds and uses thereof |
May. 19, 2009 |
| 7524879 |
Ion channel modulating compounds and uses thereof |
Apr. 28, 2009 |
| 7491745 |
Pyrrole-Type compounds, compositions and methods for treating cancer or viral disease |
Feb. 17, 2009 |
| 7485641 |
Substituted 3-amino-pyrrolidino-4-lactams |
Feb. 3, 2009 |
| 7485662 |
Therapeutic agent for diabetes mellitus |
Feb. 3, 2009 |
| 7485664 |
Inhibitors of TACE |
Feb. 3, 2009 |
| 7479506 |
Agent or method for treating severe aphasia in cerebrovascular accident chronic stage |
Jan. 20, 2009 |
| 7465751 |
1-substituted-3-pyrrolidine derivatives as muscarinic receptor antagonists |
Dec. 16, 2008 |
| 7462594 |
Peptide-like compounds that inhibit coronaviral 3CL and flaviviridae viral proteases |
Dec. 9, 2008 |
| 7456210 |
Benzyloxy derivatives |
Nov. 25, 2008 |
| 7456211 |
Peptide deformylase inhibitors |
Nov. 25, 2008 |
| 7425575 |
Spirocyclic 3-phenyl-3-substituted 4-ketolactams and 4-ketolactones |
Sep. 16, 2008 |
| 7419999 |
Gamma lactams as prostaglandin agonists and use thereof |
Sep. 2, 2008 |
| 7414071 |
Methods of treatment with selective EP4 receptor agonists |
Aug. 19, 2008 |
| 7402606 |
Derivatives of 1-(oxoaminoacetyl) pentylcarbamate as cathepsin K inhibitors for the treatment of bone loss |
Jul. 22, 2008 |
| 7402605 |
8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient |
Jul. 22, 2008 |
| 7396846 |
Growth hormone secretagogues |
Jul. 8, 2008 |
| 7345086 |
Uses of ion channel modulating compounds |
Mar. 18, 2008 |
| 7345082 |
Phosphinic acids |
Mar. 18, 2008 |
| 7345087 |
Aminocyclohexyl ether compounds and uses thereof |
Mar. 18, 2008 |
| 7338975 |
Lactams as modulators of chemokine receptor activity |
Mar. 4, 2008 |
| 7329685 |
1-Phenyl-2-oxo-3-sulfonylamino-pyrrolidine derivatives and related compounds as factor Xa inhibitors for the treatment of acute vascular diseases |
Feb. 12, 2008 |
| 7326696 |
Amino-methyl substituted tetracycline compounds |
Feb. 5, 2008 |
| 7312218 |
Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors |
Dec. 25, 2007 |
| 7304088 |
Protease inhibitors |
Dec. 4, 2007 |
| 7300929 |
Mediators of hedgehog signaling pathways, compositions and uses related thereto |
Nov. 27, 2007 |
| 7297712 |
Cationic amphiphiles for intracellular delivery of therapeutic molecules and its composition, process and method of treatment |
Nov. 20, 2007 |
| 7294647 |
Kappa agonist compounds and pharmaceutical formulations thereof |
Nov. 13, 2007 |
| 7291620 |
N-alkyl phenylcarboxamide beta-secretase inhibitors for the treatment of Alzheimer's disease |
Nov. 6, 2007 |
| 7288565 |
Azasugar compound |
Oct. 30, 2007 |
| 7276531 |
G-lactam derivatives as prostaglandin agonists |
Oct. 2, 2007 |
| 7259184 |
Ion channel modulating compounds and uses thereof |
Aug. 21, 2007 |
| 7256211 |
8-azaprostaglandin derivatives and medical use thereof |
Aug. 14, 2007 |
| 7253198 |
Hydroxyethylamine derivatives for the treatment of Alzheimer's disease |
Aug. 7, 2007 |
| 7253205 |
Gem-disubstituted cyclohexane derivatives and their use as therapeutic agents |
Aug. 7, 2007 |
|
|
|
